Bard (C.R.) Inc. (BCR)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q3  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 47.11% | 3,590 | 0.02 | |
Q2  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 7,620 | 0.03 | |
Q4  2015 | |||||
≡ | Thomas Gayner - Markel Group | Add 125.00% | 5,000 | 0.03 | |
Q3  2015 | |||||
≡ | Thomas Gayner - Markel Group | Buy | 4,000 | 0.02 | |
Q4  2014 | |||||
≡ | Meridian Contrarian Fund | Add 12.99% | 10,000 | 0.26 | |
Q3  2014 | |||||
≡ | Meridian Contrarian Fund | Add 55.56% | 27,500 | 0.60 | |
Q2  2014 | |||||
≡ | Robert Olstein - Olstein Capital Management | Add 26.67% | 8,000 | 0.18 | |
Q1  2014 | |||||
≡ | Meridian Contrarian Fund | Add 15.38% | 13,000 | 0.27 | |
Q4  2013 | |||||
≡ | Meridian Contrarian Fund | Add 32.03% | 20,500 | 0.37 | |
Q3  2013 | |||||
≡ | Meridian Contrarian Fund | Buy | 64,000 | 1.05 | |
Q1  2013 | |||||
≡ | Robert Olstein - Olstein Capital Management | Buy | 48,000 | 0.89 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.